文献速递关节外科

内侧稳定型全膝关节假体与交叉韧带保留型及后稳定型设计的随机对照试验:临床与功能结局报告

A Randomized Controlled Trial Comparing a Medial Stabilized Total Knee Prosthesis to a Cruciate Retaining and Posterior Stabilized Design: A Report of the Clinical and Functional Outcomes Following Total Knee Replacement.
PubMed 文献 · J Arthroplasty · 2020-02-07

这项随机对照试验比较了内侧稳定型(MS)、交叉韧带保留型(CR)和后稳定型(PS)三种全膝关节置换假体术后6个月的临床表现。共83例患者随机分配至PS组(n=26)、CR组(n=28)和MS组(n=29)。6个月时主要结局(牛津膝关节评分)无组间差异,但MS组膝关节协会评分2011满意度优于CR和PS组;12个月时MS组在WOMAC疼痛、功能和全局子量表上优于CR组,VR-12心理健康方面MS和PS组优于CR组。

要点

  • 6个月时MS假体在主要结局(牛津膝关节评分)上与PS和CR假体相似。
  • MS组6个月满意度(KSS 2011)优于CR和PS组。
  • 12个月时MS组在WOMAC疼痛、功能和全局子量表上优于CR组。

核心结论

  • MS假体术后6个月的临床和功能结局与PS和CR设计相似,且患者满意度更高。
  • 与CR相比,MS假体在12个月时报告了更优的疼痛、功能和生活质量结局。

研究设计与样本

  • 随机对照试验,2015年3月至2018年3月招募骨关节炎患者。
  • 83例随机分配至PS组(n=26)、CR组(n=28)和MS组(n=29)。
  • 主要结局为6个月时牛津膝关节评分自报疼痛和功能改善。
  • 次要结局包括WOMAC、VR-12、KSS 2011、TUG和6分钟步行测试,并测量12个月结局。

主要发现

  • 6个月主要结局无组间差异。
  • 6个月KSS 2011满意度:MS优于CR和PS。
  • 12个月WOMAC疼痛、功能和全局子量表:MS优于CR。
  • 12个月VR-12心理健康:MS和PS优于CR。

关键数值与推荐

  • 6个月KSS 2011满意度MS优于CR和PS。
  • 12个月WOMAC疼痛、功能和全局子量表MS优于CR。
  • 12个月VR-12心理健康MS和PS优于CR。

临床怎么用

  • MS假体可作为全膝关节置换的合理选择,6个月结局与PS和CR相当且满意度更高。
  • 对于关注12个月疼痛、功能和生活质量的患者,MS可能优于CR。

局限性

  • 样本量较小(83例随机),7例未完成所有结局测量。
  • 仅报告6个月和12个月结局,缺乏长期随访数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this randomized controlled trial was to compare the performance of 3 total knee joint replacement (TKJR) designs 6 months after the surgery. METHODS: Patients were recruited between March 2015 and March 2018. Patients with osteoarthritis consented for TKJR were randomly allocated to a medial stabilized (MS), cruciate retaining (CR), or posterior stabilized (PS) design. Primary outcome measures were self-reported improvement in pain and function 6 months after TKJR, using the Oxford Knee Score. Secondary outcome measures were the Western Ontario and McMaster Universities Osteoarthritis Index, Veterans RAND 12-item Health Survey, Knee Society Score 2011, Timed Up and Go test, and Six-Minute Walk Test. Twelve-month outcomes were also measured. RESULTS: Ninety participants enrolled, 83 were randomized: PS (n = 26), CR (n = 28), and MS (n = 29) designs. One case withdrew before surgery: planned use of non-study implant; 7 did not complete all outcome measures. No 6-month between-group difference was observed for the primary outcome. A 6-month difference was observed in Knee Society Score 2011 Satisfaction: MS favored over CR and PS. Clinically meaningful 12-month differences in Western Ontario and McMaster Universities Osteoarthritis Index Pain, Function, and Global Subscales were observed: MS favored over CR. Twelve-month differences occurred in Veterans RAND 12-item Health Survey mental well-being, favoring MS and PS over CR. CONCLUSION: MS prosthesis can be expected to yield similar clinical and functional outcomes to PS and CR designs 6 months after TKJR, and patients were more satisfied with their outcome. Compared with CR, patients with MS prosthesis also reported superior pain, function, and quality-of-life outcomes at 12 months.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Dowsey MM, Gould DJ, Spelman T, et al. A Randomized Controlled Trial Comparing a Medial Stabilized Total Knee Prosthesis to a Cruciate Retaining and Posterior Stabilized Design: A Report of the Clinical and Functional Outcomes Following Total Knee Replacement. J Arthroplasty. 2020. PMID: 32139194. doi:10.1016/j.arth.2020.01.085

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。